Top 5 Frequently Asked Questions About Tirzepatide
Our Clinic Manager, Emily, goes over the frequently asked questions we get about Tirzepatide!
Our Clinic Manager, Emily, goes over the frequently asked questions we get about Tirzepatide!
Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist.
Tirzepatide, FDA approved medication for weight loss November 9, 2023: Update on FDA approval for Tirzepatide for weight loss. A revolutionary weight loss medication, Tirzepatide, has received approval from the U.S. Food and Drug Administration (FDA), marking a significant milestone in the treatment of obesity. This novel medication has shown promising results in clinical trials, …
Tirzepatide, the new FDA approved medication for weight loss? Read More »